MITSUBISHI MP-124-A01
Study Overview
This trial is to investigate the safety, tolerability, and pharmacokinetic profiles of ascending 24- and 72- hour continuous infusions of various doses of MP-124 in acute, ischemic stroke patients. This trial is currently enrolling.
Principal Investigator
Irfan Altafullah, M.D.
Investigator(s)
Richard Peterson, M.D.
Nancy Downerd, NP-C
Research Contact
Amy Tanner at
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
or 763.520.1542
IRIS: Insulin Resistance Intervention after Stroke Trial
Study Overview
This trial is designed to determine whether Pioglitazone, compared with placebo, is effective in prevention of stroke and myocardial infarction after ischemic stroke and transient ischemic attack. This trial is currently enrolling.
Principal Investigator
Irfan Altafullah, M.D.
Investigator(s)
Richard Peterson, M.D.
Research Contact
Amy Tanner at
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
or 763.520.1542
|
